Erratum to: Biomodulatory Treatment of Patients with Castration-Resistant Prostate Cancer: A Phase II Study of Imatinib with Pioglitazone, Etoricoxib, Dexamethasone and Low-Dose Treosulfan
Titel:
Erratum to: Biomodulatory Treatment of Patients with Castration-Resistant Prostate Cancer: A Phase II Study of Imatinib with Pioglitazone, Etoricoxib, Dexamethasone and Low-Dose Treosulfan
Auteur:
Vogelhuber, M. Feyerabend, S. Stenzl, A. Suedhoff, T. Schulze, M. Huebner, J. Oberneder, R. Wieland, W. Mueller, S. Eichhorn, F. Heinzer, H. Schmidt, K. Baier, M. Ruebel, A. Birkholz, K. Bakhshandeh-Bath, A. Andreesen, R. Herr, W. Reichle, A.